Frailty, Hip Fractures and Inflammatory Biomarkers
Recruiting
Observational Study
Frailty
Hip Fracture
Inflammatory Biomarkers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- University of Thessaly · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients
Exclusion Criteria:
* Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Contacts
Maria Ntalouka, MD, PhD, MSc
CONTACT